These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Thornsberry C; Baker CN; Facklam RR Antimicrob Agents Chemother; 1974 Mar; 5(3):228-33. PubMed ID: 4840433 [TBL] [Abstract][Full Text] [Related]
3. Impact of susceptibility to antibiotics of streptococci & enterococci isolated from patients with infective endocarditis on antibiotic treatment. Mihaila-Amrouche L; Schlegel L; Bouvet A; Indian J Med Res; 2004 May; 119 Suppl():80-3. PubMed ID: 15232168 [TBL] [Abstract][Full Text] [Related]
4. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci. Watanakunakorn C; Glotzbecker C J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243 [TBL] [Abstract][Full Text] [Related]
5. Viridans streptococci in infective endocarditis: species distribution and susceptibility to antibiotics. Horaud T; Delbos F Eur Heart J; 1984 Oct; 5 Suppl C():39-44. PubMed ID: 6519085 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the combination effects of ampicillin or vancomycin combined with streptomycin, gentamicin, tobramycin or netilmicin against enterococci. Fuursted K APMIS; 1989 Jan; 97(1):23-6. PubMed ID: 2914103 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988. Watanakunakorn C J Antimicrob Chemother; 1989 Jul; 24(1):63-8. PubMed ID: 2506165 [TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of 56 strains of Streptococcus group B to 12 antibiotics: its determination by dilution and diffusion in agar]. Giventel' NI; Osmanov SK; Bogdanova LF; Vorob'eva LS; Bochkov IA Antibiotiki; 1984 Nov; 29(11):814-9. PubMed ID: 6395791 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic-resistant oral streptococci in dental patients susceptible to infective endocarditis. Longman LP; Pearce PK; McGowan P; Hardy P; Martin MV J Med Microbiol; 1991 Jan; 34(1):33-7. PubMed ID: 1990136 [TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of fourteen antibiotics against clinical isolates of enterococci. Abd-Elalim Eltahawy AT; Fouad Khalaf RM J Chemother; 1990 Dec; 2(6):351-4. PubMed ID: 2093105 [TBL] [Abstract][Full Text] [Related]
11. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907 [TBL] [Abstract][Full Text] [Related]
12. [Enterococci: high level of resistance to aminoglycosides]. del Valle-Ortiz O; Gallés C; Codina G; Cano A Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):535-41. PubMed ID: 2490431 [TBL] [Abstract][Full Text] [Related]
13. [Susceptibility to betalactam antibiotics, glycopeptides and aminoglycosides in commensal strains of erythromycin-resistant alpha-hemolytic streptococci and Gemella spp]. Cerdá-Zolezzi P; Goñi-Cepero P; Millán-Laplana L; Rubio-Calvo C; Durán E; Oca M; Gómez-Lus R Enferm Infecc Microbiol Clin; 2008 Jan; 26(1):4-9. PubMed ID: 18208759 [TBL] [Abstract][Full Text] [Related]
14. Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis. Kikuchi K; Enari T; Minami S; Haruki K; Shibata Y; Hasegawa H; Katahira J; Totsuka K; Shimizu K J Antimicrob Chemother; 1994 Nov; 34(5):687-96. PubMed ID: 7706164 [TBL] [Abstract][Full Text] [Related]
15. [Non-groupable streptococci: identification, sensitivity to antibiotics (Charles Nicolle Hospital in Tunis)]. Kechrid A; Ben Redjeb S; Gargouri J; Fendri C; Ben Hassen E; Boujnah A Med Trop (Mars); 1991; 51(2):181-4. PubMed ID: 1895917 [TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of five combinations of penicillin G with aminoglycosides against Streptococcus faecium. Le Bouguenec C; Buu-Hoï A Eur Heart J; 1984 Oct; 5 Suppl C():29-32. PubMed ID: 6569841 [TBL] [Abstract][Full Text] [Related]
17. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin. García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM; Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Streptococcus mutans isolated from patients with endocarditis. Baker CN; Thornsberry C Antimicrob Agents Chemother; 1974 Mar; 5(3):268-71. PubMed ID: 4840435 [TBL] [Abstract][Full Text] [Related]
19. Amoxycillin-resistant oral streptococci and experimental infective endocarditis in the rabbit. Longman LP; Marsh PD; Martin MV J Antimicrob Chemother; 1992 Sep; 30(3):349-52. PubMed ID: 1452500 [TBL] [Abstract][Full Text] [Related]
20. Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides. Murray BE; Tsao J; Panida J Antimicrob Agents Chemother; 1983 Jun; 23(6):799-802. PubMed ID: 6614889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]